Announce Date | 05/30/2024 |
EPS Normalized Actual | $0.38 (Beat by $0.0241) |
EPS GAAP Actual | $0.38 (Beat by $0.0241) |
Revenue Actual | $3.09656B |
Revenue Surprise | Beat by $3096.56M |
Announce Date | 07/30/2024 (Pre-Market) |
EPS Normalized Estimate | $1.33835 |
EPS GAAP Estimate | $1.33835 |
Revenue Estimate | $5.926598B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Oct 2026 | 2.39 | 13.42 | 2.39 | 2.39 | 1 |
Oct 2026 | 1.87004 | 17.15 | 1.86 | 1.89 | 3 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2022 (May 2022) | 0.48 | 0.48 | 3.09656B | 15.82% | 3096.56M |
FQ1 2022 (Jan 2022) | 0.44 | 0.44 | 3.04436B | 19.16% | 3044.36M |
FQ4 2021 (Oct 2021) | 0.52 | 0.52 | 3.45475B | 29.95% | 3454.75M |
FQ3 2021 (Jul 2021) | 0.33 | 0.33 | 2.86367B | 16.84% | 2863.67M |
FQ2 2021 (Apr 2021) | 0.42 | 0.42 | 2.60662B | 7.06% | 2606.62M |
FQ1 2021 (Jan 2021) | 0.41 | 0.41 | 2.46115B | 3.12% | 2461.15M |
FQ4 2020 (Oct 2020) | 0.43 | 0.43 | 2.42011B | -3.36% | 2420.11M |
FQ3 2020 (Jul 2020) | 0.38 | 0.38 | 2.38146B | 3.81% | 2381.46M |
FQ4 Announce Date
07/30/2024 (Pre-Market)
Consensus EPS Estimates
1.33835
Consensus Revenue Estimates
5.926598B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Oct 2026) | 0.54 | -- | 0.5328 | 0.54857 | 4 |
FQ3 2026 (Jul 2026) | 0.5 | -- | 0.49333 | 0.50794 | 4 |
FQ2 2026 (Apr 2026) | 0.46 | -- | 0.45387 | 0.4673 | 4 |
FQ1 2026 (Jan 2026) | 0.43 | -- | 0.42427 | 0.43682 | 4 |
FQ4 2025 (Oct 2025) | 0.47575 | -- | 0.46941 | 0.4833 | 3 |
FQ3 2025 (Jul 2025) | 0.41625 | -- | 0.4107 | 0.42286 | 3 |
FQ2 2025 (Apr 2025) | 0.39725 | -- | 0.39195 | 0.40355 | 3 |
FQ1 2025 (Jan 2025) | 0.36425 | -- | 0.35939 | 0.37003 | 3 |
FQ4 2024 (Oct 2024) | 0.44721 | -- | 0.44125 | 0.45431 | 2 |
FQ3 2024 (Jul 2024) | 1.33835 | -- | 1.20778 | 1.40364 | 6 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Oct 2026) | 3.36B | -- | 3.33B | 3.41B | 2 |
FQ3 2026 (Jul 2026) | 3.11B | -- | 3.08B | 3.15B | 2 |
FQ2 2026 (Apr 2026) | 3.04B | -- | 3B | 3.07B | 2 |
FQ1 2026 (Jan 2026) | 3.01B | -- | 2.98B | 3.05B | 2 |
FQ4 2025 (Oct 2025) | 3.3B | -- | 3.27B | 3.34B | 1 |
FQ3 2025 (Jul 2025) | 2.99B | -- | 2.96B | 3.03B | 1 |
FQ2 2025 (Apr 2025) | 3.05B | -- | 3.02B | 3.09B | 1 |
FQ1 2025 (Jan 2025) | 2.97B | -- | 2.94B | 3.01B | 1 |
FQ4 2024 (Oct 2024) | 3.26B | -- | 3.23B | 3.3B | 2 |
FQ3 2024 (Jul 2024) | 5.93B | -- | 5.4B | 6.44B | 19 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2022 (May 2022) | 0.48 | 0.48 | 100% | |
FQ1 2022 (Jan 2022) | 0.44 | 0.44 | 100% | |
FQ4 2021 (Oct 2021) | 0.52 | 0.52 | 100% | |
FQ3 2021 (Jul 2021) | 0.33 | 0.33 | 100% | |
FQ2 2021 (Apr 2021) | 0.42 | 0.42 | 100% | |
FQ1 2021 (Jan 2021) | 0.41 | 0.41 | 100% | |
FQ4 2020 (Oct 2020) | 0.43 | 0.43 | 100% | |
FQ3 2020 (Jul 2020) | 0.38 | 0.38 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2022 (May 2022) | $0B | $3.1B | $3096.56M | 100% |
FQ1 2022 (Jan 2022) | $0B | $3.04B | $3044.36M | 100% |
FQ4 2021 (Oct 2021) | $0B | $3.45B | $3454.75M | 100% |
FQ3 2021 (Jul 2021) | $0B | $2.86B | $2863.67M | 100% |
FQ2 2021 (Apr 2021) | $0B | $2.61B | $2606.62M | 100% |
FQ1 2021 (Jan 2021) | $0B | $2.46B | $2461.15M | 100% |
FQ4 2020 (Oct 2020) | $0B | $2.42B | $2420.11M | 100% |
FQ3 2020 (Jul 2020) | $0B | $2.38B | $2381.46M | 100% |